Pelthos Therapeutics Ownership & Insider Activity

Pelthos Therapeutics (PTHS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 10.9% of shares outstanding. Institutional investors hold 5.0%. Over the past 90 days, insiders made 3 sales worth $45K.

Shares Outstanding

3.828M

Shares Float

2.067M

Insider Shares Owned

417.893K

Insider % Owned

10.9%

Institutional Shares Held

191.748K

Institutional % Held

5.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$45K total

Net Activity

Net Selling

Net Value (90d)

-$45K

Pelthos Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 2, 2026	Peter Greenleaf	DIRECTOR	SELL	797.000	$21.17	$17K
Oct 2, 2026	Ezra Friedberg	DIRECTOR	SELL	558.000	$20.72	$12K
Oct 2, 2026	Matthew Pauls	DIRECTOR	SELL	786.000	$21.00	$17K
Jul 2, 2026	Ezra Friedberg	DIRECTOR	SELL	558.000	$26.09	$15K
Jul 2, 2026	Matthew Pauls	DIRECTOR	SELL	786.000	$26.16	$21K
Jul 2, 2026	Peter Greenleaf	DIRECTOR	SELL	797.000	$26.13	$21K
Jun 15, 2026	Ezra Friedberg	DIRECTOR	SELL	283.000	$27.29	$8K
Jun 11, 2026	Todd Davis	DIRECTOR	BUY	35.948K	$27.82	$1000K
May 22, 2026	Francis Knuettel II	CFO, TREAS & SECTY	SELL	15.447K	$26.84	$40K